Pfizer throwing money to buy 700 million experimental drug Dimebon-Pfizer, drug, Dimebon-pharmaceutical industries

Pfizer throwing money to buy 700 million experimental drug Dimebon-Pfizer

, drug, Dimebon-pharmaceutical industries

Recently, Pfizer agreed to pay San Francisco-based Medivation Inc. up to 725 million U.S. dollars of funds to be used to treat other developed experimental Alzheimer's drug Dimebon. This is the world's largest pharmaceutical companies in deals this year, the ninth operation. Under the agreement, Medivation will receive Pfizer USD 225 million down payment, as well as drug listing process, linked to up to 5 million milestone payment.

Hot Present, pharmaceutical companies are racing to develop for the treatment of Alzheimer's disease drug. Analysts believe that 2012, the size of this market could grow to 20 billion U.S. dollars. Although Pfizer has been on sale for Alzheimer's disease therapy Aricept, but in 2010, the drug will face competition from generic drug companies, while the other is developing Alzheimer's Treatment drugs have not yet entered the final testing stage. Therefore, the transaction may help Pfizer in the treatment of Alzheimer's disease to achieve a quantum leap in the field, and with the development of such drugs, Lilly, Wyeth and Elan Corporation to compete.

Pfizer has the world's best-selling drug Lipitor last year, this reduction Cholesterol Drug sales 12.7 billion. However, Lipitor will lose patent protection in 2011 and faces generic competition this end, the hands hold 29,000,000,000 US dollars cash, Pfizer is searching for new drugs to cover sales of Lipitor left empty .

Analyst at Miller Tabak in New York LesFuntleyder that, although Alzheimer's disease is a difficult to treat disease, but Pfizer, this deal appears to be a positive risk-return opportunities, if Pfizer wants to make up for the next few years will experience significant economic losses, it needs to continue aggressive.

Two companies will share development and marketing in the United States, of which 60% of the cost of Pfizer's commitment to share in the United States to achieve 60% profit. Pfizer will be responsible for sales outside the United States Dimebon, Medivation Inc. to pay the sales commission. In order to be allowed in the U.S. market, Medivation and Pfizer Inc. are jointly carrying out the work of the last test in order to make good to the U.S. regulatory approval for preparation.

High hopes Medivation Inc. was founded in 2003, currently has 40 employees. In the second quarter, Medivation losses amounted to 18.5 million U.S. dollars, compared with last year's 7.2 million U.S. dollars increased substantially. Medivation's Dimebon is the main product. 80s of last century, it first as an antihistamine in Russia. To the 90's, the Russian chemist SergeyBachurin in a variety of laboratory animal tests showed that the drug has the potential to improve the animal's cognitive abilities. But in the United States, almost no attention to these findings, until the bio-technology entrepreneurs DavidHung discovered in 2003, these studies, the situation began to change. DavidHung visit to Russia in the field heard the results, he decided to set Medivation Inc., began commercial operation of the drug.

Pennsylvania RaymondMyers Emerging Growth Equities analyst, said Pfizer is a great Cooperation Partners, it has tremendous marketing tentacles, especially in the areas of primary health care; Pfizer With Aricept Alzheimer's disease treatment in a leading position in the field.

According to the British medical journal "Lancet" published in July a study, Dimebon may help Alzheimer's patients remember the date, understand medication instructions, follow commands, memorize some words and perform simple activities

POST COMMENT

Anti-ischemic drug to be a breakthrough - drug research - the pharmaceutical industries Antipsychotics -- The Top-Selling Prescription Drug in the US States' Battle over Legitimacy of Medical Cannabis Weight Loss Without Drugs - 7 Simple Steps Amendment 20: The Key to Medical Marijuana Rights in Colorado Medical Students Use Portable Pulse Oximeter Technology For Training Natural Complementary Medicine Look To Discount Drugs To Lessen The Remedy Burden People have Growing Enthusiasm on Plant Medicine Plant Medicine for Warts The Benefits of a Medical Call Center Medical Chart Reviewers How to Train for an Emergency Medical Technician Career